Navigation Links
Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells

ard treatment for APL. Recent information indicates that the combination of the vitamin A derivative retinoic acid, arsenic and chemotherapy may cure over 90% of APL patients, which may result in extending the lives of an estimated 50,000 people a year.

About SWCRF

Now in its 32nd year, the Samuel Waxman Cancer Research Foundation (SWCRF) is a unique non-profit international organization dedicated to supporting focused concept-driven research to develop targeted cancer cell-specific therapies with minimal toxicity, such as differentiation therapy. Two drugs developed through Foundation-supported research, and now used worldwide, have proven the effectiveness of non-toxic differentiation in the treatment of acute promyelocytic leukemia (APL).

Since its inception, SWCRF has trained and supported more than 170 scientists with research grants exceeding $60 million. Based in New York City at The Mount Sinai Medical Center, the Foundation funds highly collaborative basic, translational and clinical research groups throughout the United States, Canada, China, Europe and Israel. SWCRF grant applicants are established investigators who agree to collaborate with other SWCRF investigators on all research projects funded by the Foundation.

Functioning as an "Institute Without Walls" the Foundation currently enables the collaboration of accomplished scientists in 28 different world-renown cancer research centers around the world. SWCRF hosts international conferences that bring together differentiation therapy investigators in a major forum to share their findings with the scientific community. Foundation-supported projects are reviewed and evaluated annually by an independent external committee of eminent scientists.

The Foundation derives most of its support from individual contributions. For the third consecutive year, Charity Navigator has awarded SWCRF its coveted four-star rating, indicating that the Foundation operates in the most fiscal
'"/>




Page: 1 2 3

Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Stanford Researchers Find Brain Pathway of Depression in Rats
3. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
4. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
5. Researchers Discover Method for Identifying How Cancer Evades the Immune System
6. Infertile Voice Supports Stem Cell Research: RESOLVE Calls for Patient Options in Using Frozen Embryos
7. Fact Sheet: Advancing Stem Cell Research While Respecting Moral Boundaries
8. President Bush Ignores Americas Plea for Support of Stem Cell Research
9. Researchers Discover Gene For Rare Skin Disorder
10. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
11. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine

Post Your Comments:
(Date:11/6/2009)... PARIS, November 6 , - ...Linezolid for the,Treatment of Multi-Resistant Sta...vexel, a speciality pharmaceutical company focused...tics designed to overcome the significant global,p...at its most advanced oral,antibacterial NXL103 (fl...
(Date:11/5/2009)...OINT RICHMOND, Calif., Nov. 5 /PRNewswire-FirstCal...PT ), a specialty pharmaceutical company focused o...tary products that address important therapeutic n... it will host a webcast and teleconference with ma...esults on Thursday, November 12, 2009, at 5:00 p.m...
(Date:11/5/2009)...ULLERTON, Calif., Nov. 5 Renee Cob...ate professor of dermatology at the University of ...nts are experiencing tremendous results with Therm...ed for skin tightening and contouring, features a ...efficacy and improves patient comfort. ,, "The...
Breaking Medicine Technology:Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2What are the most effective ways of promoting physical exercise in adults 3F 51564 1What are the most effective ways of promoting physical exercise in adults 3F 51564 2What are the most effective ways of promoting physical exercise in adults 3F 51564 3Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 1Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 2Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 3Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 4Pelosi Statement on Appointment of Dr Regina Benjamin as Surgeon General of the United States 51560 1
...or Cancer Research meeting indicate that technolo...-water-soluble drugs to treat cancer and possibly ...r Pharmaceuticals today,reported results on a nove...pable of dissolving in water (hydrophobic drugs) i...ation. These findings allow the company to,combine...
...MOND, Va., April 16 Insmed Inc. (Nasdaq:,INSM), a...ticals, today,announced that it has received appro...care products Regulatory Agency (MHRA) to initiate...n biologic (FOB) product candidate.,Insmed,s INS-1...a follow-on,biologic of the FDA-approved product N...
Other Medicine Technology:Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations 2Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 2Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 4
(Date:11/8/2009)... , A jury of 8 people in ...te County woman $2,300,000 in pain and suffering f...renney, James Tallman and Alicia Nocera of Thomas ... behalf of the plaintiff, Vita Monestersky and aga...e an emergency total abdominal hysterectomy at age...
(Date:11/8/2009)... , WASHINGTON, Nov. 8 /PRNewswire-USNewswire/...merica (PhRMA) Senior Vice President Ken Johnson r...e health care reform bill: ,, "We are disappoin...iness echoed by millions of hardworking Americans ...House of Representatives who voted against the bil...
(Date:11/8/2009)... , AARP Praises House Passage of Health Care...rengthen Medicare, improve coverage for all Americ...e/ -- SUMMARY: Tonight the United States House o...rm legislation that would strengthen Medicare for ...ies that prices millions of Americans out of affor...
(Date:11/7/2009)... , HOUSTON, Nov. 7 ...esented Lisa James, Director of Health at the Fami... Distinguished Service today at its semi-annual po...ed Service is the highest honor the AMA House of D...: http://www.newscom.com/cgi-bin/prnh/20081209/...
(Date:11/7/2009)... , Brown: "Faithful Catholics have a respon...re, not negotiate the status quo." ,, WASHING... Life League president Judie Brown released the fo... Rigali will support Speaker Nancy Pelosi,s Afford...ided an amendment preserving the status quo for ab...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2
...Ohio, Jan. 30 Cardinal Health Chief,Executive Off...erbeck, will,address investors at the Merrill Lync... Device Conference in New York on Feb. 7 at 9:20 a...ntinued growth. His,remarks will be webcast live. ...
...TI, Jan. 30 , CALL DATE: Wednesday, F...tern Time HOST: Dr. Candace Kend... conduct a telephone conference call and,simultane...wer session will follow., (Logo: http://www.news...
...ealthcare to Offer Unique and Cost-Effective Appro... Clinical Outcomes, TORONTO and PHOENIX, Jan. 30 ...ns and health information solution provider,based ...n Phoenix, Arizona, to provide its innovative inte...
...Mich., Jan. 30 The Michigan Business and,Professi...ociation Michigan,Food and Beverage Association (M...at employ over 180,000 individuals throughout the ... Senate,approval. "With today,s economy in mind, w...
...nt and Vestar Capital Partners Purchase Interest f...al Partners, SOUTH BEND, Ind. and NEW YORK, Jan. ...ider of health care performance,improvement soluti...Securities Capital Partners, LLC (ASCP). The,Press...
...CITY, Calif. and FORT LAUDERDALE, Fla., Jan. 30, C...,its innovative C-Port(R) Distal Anastomosis Syste...acic surgeons at the 2008 STS University. In,addit...eting of The Society of Thoracic Surgeons (STS) in...
Other Medicine News:Health News:Cardinal Health CEO of Clinical & Medical Products to Speak at Merrill Lynch's Global Pharmaceutical, Biotechnology and Medical Device Conference 2Health News:Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast 2Health News:Life:WIRE(TM) to Provide Action Healthcare Management with Innovative Mobile Health Management Solution for Patients with Chronic Conditions 2Health News:Individual Healthcare Reform Necessity in New Business Economy 2Health News:Press Ganey Takes on New Investment Partner 2Health News:Press Ganey Takes on New Investment Partner 3Health News:Press Ganey Takes on New Investment Partner 4Health News:Cardica's C-Port Anastomosis Systems for Coronary Artery Bypass Graft Procedures to be Used to Train Cardiothoracic Surgeons at Society of Thoracic Surgeons (STS) University 2Health News:Cardica's C-Port Anastomosis Systems for Coronary Artery Bypass Graft Procedures to be Used to Train Cardiothoracic Surgeons at Society of Thoracic Surgeons (STS) University 3
...AREDS formula is the one and only vitamin and mine...nstitute's age-related eye study (AREDS) 10-year t...cal Age-Related Eye Disease Study (AREDS) by the N...Institutes of Health) showed that a unique vitamin...
Ocuvite® Eye Vitamins and Mineral Supplement
...aps, the patented next-generation dietary suppleme...systemically address the root inflammatory cause a... peer-reviewed literature that these specific nutr...ther affected parts of the body, such as mucous me...
...the industry-leading portal to QC information, pro... way to access their quality control data and othe...b enables Bio-Rad customers to access on-demand (I...s, as well as convenient online data entry and man...
Medicine Products: